We generated stable LCN2‐knockdown cell lines [SUM149 (triple‐negative IBC); MDA‐IBC3 (HER2+ IBC)] to investigate the role of LCN2 in IBC aggressiveness in vitro and in vivo. This evidence concerns the gene LCN2 and inflammatory breast carcinoma.